Grove Bank & Trust’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $213K | Sell |
5,000
-30
| -0.6% | -$1.34K | 0.02% | 259 |
|
|
2026
Q1 | $242K | Sell |
5,030
-140
| -3% | -$6.53K | 0.03% | 236 |
|
|
2025
Q4 | $251K | Buy |
5,170
+170
| +3% | +$8.43K | 0.03% | 238 |
|
|
2025
Q3 | $236K | Hold |
5,000
| – | – | 0.03% | 236 |
|
|
2025
Q2 | $242K | Hold |
5,000
| – | – | 0.03% | 226 |
|
|
2025
Q1 | $277K | Hold |
5,000
| – | – | 0.04% | 203 |
|
|
2024
Q4 | $241K | Sell |
5,000
-691
| -12% | -$35.1K | 0.03% | 206 |
|
|
2024
Q3 | $328K | Buy |
5,691
+300
| +6% | +$16.2K | 0.05% | 174 |
|
|
2024
Q2 | $262K | Sell |
5,391
-190
| -3% | -$9.16K | 0.04% | 185 |
|
|
2024
Q1 | $271K | Sell |
5,581
-8,179
| -59% | -$399K | 0.05% | 186 |
|
|
2023
Q4 | $684K | Sell |
13,760
-2,934
| -18% | -$143K | 0.13% | 122 |
|
|
2023
Q3 | $895K | Buy |
16,694
+1,958
| +13% | +$104K | 0.18% | 102 |
|
|
2023
Q2 | $794K | Buy |
14,736
+617
| +4% | +$33.2K | 0.16% | 108 |
|
|
2023
Q1 | $768K | Buy |
14,119
+7,961
| +129% | +$387K | 0.16% | 110 |
|
|
2022
Q4 | $298K | Hold |
6,158
| – | – | 0.07% | 183 |
|
|
2022
Q3 | $234K | Sell |
6,158
-714
| -10% | -$31.8K | 0.06% | 191 |
|
|
2022
Q2 | $344K | Sell |
6,872
-1
| -0% | -$53 | 0.08% | 164 |
|
|
2022
Q1 | $353K | Hold |
6,873
| – | – | 0.07% | 178 |
|
|
2021
Q4 | $345K | Hold |
6,873
| – | – | 0.07% | 184 |
|
|
2021
Q3 | $331K | Hold |
6,873
| – | – | 0.07% | 180 |
|
|
2021
Q2 | $362K | Sell |
6,873
-3
| -0% | -$157 | 0.08% | 167 |
|
|
2021
Q1 | $340K | Sell |
6,876
-253
| -4% | -$12.2K | 0.08% | 165 |
|
|
2020
Q4 | $346K | Buy |
7,129
+202
| +3% | +$9.96K | 0.09% | 152 |
|
|
2020
Q3 | $348K | Sell |
6,927
-513
| -7% | -$26.4K | 0.11% | 140 |
|
|
2020
Q2 | $380K | Sell |
7,440
-521
| -7% | -$25.3K | 0.13% | 132 |
|
|
2020
Q1 | $348K | Sell |
7,961
-384
| -5% | -$18.4K | 0.14% | 130 |
|
|
2019
Q4 | $419K | Sell |
8,345
-2,361
| -22% | -$111K | 0.13% | 134 |
|
|
2019
Q3 | $497K | Sell |
10,706
-133
| -1% | -$5.74K | 0.16% | 125 |
|
|
2019
Q2 | $469K | Sell |
10,839
-1,861
| -15% | -$79.1K | 0.17% | 116 |
|
|
2019
Q1 | $562K | Sell |
12,700
-561
| -4% | -$24K | 0.22% | 103 |
|
|
2018
Q4 | $576K | Sell |
13,261
-1,849
| -12% | -$81.5K | 0.27% | 91 |
|
|
2018
Q3 | $675K | Sell |
15,110
-1,206
| -7% | -$51.5K | 0.28% | 87 |
|
|
2018
Q2 | $653K | Sell |
16,316
-199
| -1% | -$7.83K | 0.28% | 91 |
|
|
2018
Q1 | $662K | Buy |
16,515
+456
| +3% | +$19K | 0.29% | 88 |
|
|
2017
Q4 | $691K | Sell |
16,059
-802
| -5% | -$37K | 0.3% | 83 |
|
|
2017
Q3 | $840K | Buy |
16,861
+1,826
| +12% | +$88.4K | 0.41% | 62 |
|
|
2017
Q2 | $720K | Buy |
15,035
+1,141
| +8% | +$54.5K | 0.46% | 54 |
|
|
2017
Q1 | $629K | Buy |
13,894
+571
| +4% | +$24.2K | 0.52% | 46 |
|
|
2016
Q4 | $538K | Sell |
13,323
-236
| -2% | -$9.3K | 0.41% | 60 |
|
|
2016
Q3 | $518K | Buy |
13,559
+2,490
| +22% | +$99.9K | 0.44% | 57 |
|
|
2016
Q2 | $463K | Buy |
11,069
+7,051
| +175% | +$289K | 0.41% | 57 |
|
|
2016
Q1 | $161K | Sell |
4,018
-605
| -13% | -$24.3K | 0.15% | 100 |
|
|
2015
Q4 | $197K | Buy |
+4,623
| New | +$213K | 0.18% | 93 |
|
Other funds holding SNY
DC
QCM
MFG
FBT
FB
CAMG
PCM
PAS
Grove Bank & Trust's SNY Position: Q2 2026 in Review
Grove Bank & Trust reduced its Sanofi (SNY) stake by 0.6% in Q2 2026, selling an estimated $1.34K and leaving 5,000 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #259.
Grove Bank & Trust first reported a position in SNY in Q4 2015 and has held it in 43 quarters since. The position peaked at $895K in Q3 2023. 104 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Grove Bank & Trust held 5,000 shares of Sanofi worth $213K as of Q2 2026.
- Grove Bank & Trust sold 30 Sanofi shares in Q2 2026, an estimated $1.34K.
- Sanofi made up 0.02% of Grove Bank & Trust's portfolio in Q2 2026, its #259 holding.
- Grove Bank & Trust first reported a position in Sanofi in Q4 2015 and has held it in 43 quarters since.
- Grove Bank & Trust's Sanofi position peaked at $895K in Q3 2023.
- 104 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.